Fresenius Medical Care AG FMCQF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.63B | 22.66B | 22.45B | 22.19B | 21.71B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.63B | 22.66B | 22.45B | 22.19B | 21.71B |
| Cost of Revenue | 16.65B | 16.69B | 16.62B | 16.49B | 16.28B |
| Gross Profit | 5.99B | 5.97B | 5.83B | 5.69B | 5.43B |
| SG&A Expenses | 3.50B | 3.47B | 3.51B | 3.43B | 3.41B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 17.83M | -2.48M | -26.44M | -37.46M | -35.73M |
| Total Operating Expenses | 20.35B | 20.34B | 20.28B | 20.06B | 19.83B |
| Operating Income | 2.28B | 2.32B | 2.16B | 2.13B | 1.87B |
| Income Before Tax | 1.63B | 1.75B | 1.70B | 1.72B | 1.32B |
| Income Tax Expenses | 368.00M | 366.36M | 350.70M | 364.92M | 306.03M |
| Earnings from Continuing Operations | 1.26K | 1.38K | 1.35K | 1.36K | 1.02K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -304.33M | -290.93M | -257.31M | -242.44M | -209.80M |
| Net Income | 956.15M | 1.09B | 1.10B | 1.12B | 807.38M |
| EBIT | 2.28B | 2.32B | 2.16B | 2.13B | 1.87B |
| EBITDA | 3.74B | 3.78B | 3.61B | 3.55B | 3.30B |
| EPS Basic | 3.48 | 3.88 | 3.80 | 3.85 | 2.76 |
| Normalized Basic EPS | 3.34 | 3.47 | 3.36 | 3.30 | 2.88 |
| EPS Diluted | 3.47 | 3.87 | 3.80 | 3.84 | 2.75 |
| Normalized Diluted EPS | 3.34 | 3.47 | 3.36 | 3.30 | 2.88 |
| Average Basic Shares Outstanding | 1.09B | 1.12B | 1.15B | 1.16B | 1.17B |
| Average Diluted Shares Outstanding | 1.09B | 1.12B | 1.15B | 1.16B | 1.17B |
| Dividend Per Share | 1.73 | 1.73 | 1.73 | 1.73 | 1.54 |
| Payout Ratio | 48.68% | 42.56% | 43.78% | 42.94% | 59.39% |